Position in CDXS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$283,546
+$169,449 QoQ
Shares Held
173,955
+148.5% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,114,640,973 across 347 Biotechnology names. CDXS ranks #269 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $283,546 | 173,955 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $114,097 | 69,999 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $121,393 | 49,752 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $130,163 | 53,346 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $165,597 | 61,561 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $363,974 | 76,305 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $171,604 | 55,716 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $167,573 | 54,056 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $243,405 | 69,744 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $495,645 | 162,507 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $388,611 | 205,616 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $698,548 | 249,482 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,584,162 | 382,648 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,652,049 | 354,517 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,763,137 | 290,947 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,804,359 | 172,501 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $545,273 | 26,444 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,186,569 | 37,946 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,346,823 | 57,903 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,439,271 | 63,516 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $688,827 | 30,093 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $509,641 | 23,346 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $699,068 | 59,546 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $723,977 | 63,507 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $443,138 | 39,708 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||